Dr. Vikas Gupta

Dr. Vikas Gupta is an experienced Cancer Surgeon practising in Mumbai and Navi Mumbai. He completed his MS from Lokmanya Tilak Municipal Medical College, Mumbai, and DNB in Surgical Oncology from Basavatarakam Indo-American Cancer Hospital, Hyderabad. He also pursued a fellowship in GI & HPB Surgery at Tata Memorial Hospital, Mumbai. With over 10 years of experience, he specialises in minimally invasive (laparoscopic and robotic) cancer surgeries and treats a wide range of cancers, including breast, head & neck, thoracic, gastrointestinal, and genitourinary cancers. His focus is on organ-preservation techniques and delivering patient-centric, evidence-based care with the best possible outcomes.

Treatments/Procedures Offered

• Breast Cancer
• Head and Neck Cancer
• Gastrointestinal Cancer
• Gynecologic Cancer
• Genitourinary Cancer
• Thoracic Cancer

Name of Institue(s)

• MBBS - Maharashtra University of Health Sciences, Nashik, 2011’
• MS (General Surgery) - LTMH Medical College (2014)
• DNB (Surgical Oncology) - Basavatarakam Indo-American Cancer Hospital & Research Institute (2018)

Fellowships

• Fellowship in Minimal Access Surgery
• Fellowship in GI & HPB Oncology, Tata Memorial Hospital, Mumbai
• Fellow, European Board of Surgical Oncology

• International Federation of Head and Neck Oncosurgeons conference, Poster presentation, 2016 at Delhi, India - 2016.
• International Federation of Head and Neck Oncosurgeons, Poster presentation, 2016 at Delhi, India - 2016.
• Indian Cancer Congress (ICC)- 2nd prize-2017 at Bangalore, India - 2018.
• Annual National Conference of Indian Association of Surgical Oncology (NATCON), Video presentation, 3rd prize? NATCON 2018 at Trivandrum - 2018.
• Society of Surgical Oncology (SSO 2018), Poster Presentation -Chicago, USA. Bursary Award - 2018.
• Chinese Society of Clinical Oncology Conference (CSCO 2018), Oral presentation- Xiamen, China. Bursary Award - 2018.
• Seoul International Cancer Symposium (SISSO 2019)- Oral presentation - Seoul, South Korea. Outstanding poster award - 2019.
• European society of surgical oncology conference ( ESSO 39), Poster Presentation - Rotterdam, Netherlands, 2019. Bursary Award - 2019.
• HPB Week- Oral presentation - Seoul, South Korea. 2020 - 2020.
• AMASICON, 2020, West Zone Round Winner - 2020.
• European Board of Surgical Oncology qualification exam - Fellowship of the European Board of Surgeons (F.E.B.S.) - 2020.
• MRCS part A - 2020.
• MRCS (Part A) - 2020.

• 2018 - 2019 Consultant Surgical Oncology at Indo American Cancer Hospital, Hyderabad.
• 2019 - 2020 Speciality Senior Resident, GI and HPB oncology at TATA Memorial Hospital.
• 2020 - 2021 Fellow in GI & HPB surgery at TATA Memorial Hospital
• 2014 - 2015 Specialty Medical Officer at KEM hospital and Seth G.S. medical college
• 2014 - 2014 Resident at Department of Plastic Surgery

• Mohan Achyut Joshi, Minakshi Gadhire, Gaurav Mishra, Jaskaran Singh Saini, Vikas Gupta. “A rare case of obstructed Morgagni’s hernia presenting in a child (Journal of Evolution of Medical and Dental Sciences 2013).
• Gaurav Mishra, Minakshi Gadhire, Mohan A Joshi, Jaskaran Singh Saini, Vikas Gupta. “A Rare Case of Perforated Meckel's Diverticulum Following Blunt Abdominal Trauma in a Child”. (International Journal of Case Reports in Medicine, Vol. 2014 (2014)).
• Goel V, Ramani, K., Raju, K., Gupta Vikas et al. Various Clinicopathological Factors Impacting Recurrence in Stage I Endometrial Cancer: A Retrospective Study. (Indian J Gynecol Oncol (2019)).
• Gupta V, Rao T.S, Iyer R.R. et al. Feasibility of Performing Laparoscopic Completion Staging in Incidentally Diagnosed Early-Stage Ovarian Carcinoma Patients. (Indian J Gynecol Oncol (2019)).
• Gupta V, Raju K. & Fonseca, D. Primary Ewing's Sarcoma /Primitive Neuroectodermal Tumour (PNET) of the Breast: a Rare Tumour. (Indian J Surg (2019)).
• Gupta V, Raju K, Rao TS, et al. A Randomised Trial Comparing the Efficacy of Methylene Blue Dye Alone Versus a Combination of Methylene Blue Dye and Radioactive Sulphur Colloid in Sentinel Lymph Node Biopsy for Early Stage Breast Cancer Patients. (Indian Journal of Surgical Oncology. 2020).
• Gupta V, Rao C, Raju K.V.V.N. et al. Tracheal/Laryngeal Infiltration in Thyroid Cancer: a Single-Centre Experience. (Indian J Surg Oncol 11, 75–79 (2020)).
• Gupta V, Raju KVVN, Sridhar D, Ahmed SM, Fonseca D. Primary Ewing's Sarcoma/Primitive Neuroectodermal Tumour of the Cervix: a Rare Tumour. (Indian J Surg Oncol. 2020).
• Gupta V, Chaudhari V, Shrikhande SV, Bhandare MS. Does Preoperative Serum Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR), and Lymphocyte to Monocyte Ratio (LMR) Predict Prognosis Following Radical Surgery for Pancreatic Adenocarcinomas? Results of a Retrospective Study. (J Gastrointest Cancer. 2021).
• Gupta V, Giridhar, A., Sharma, R. et al. Malignancy in an Undescended Intra-abdominal Testis: a Single Institution Experience. (Indian J Surg Oncol (2021)).
• Amir Parray, Vikas Gupta, Vikram A. Chaudhari, Shailesh V. Shrikhande, Manish S. Bhandare. Role of Intraperitoneal Chemotherapy in Gastric Cancer. (Surgery in Practice and Science 4 (2021)).
• Gupta V, Bhandare MS, Chaudhari V, Parray A, Shrikhande SV. Organ-preserving pancreatic resections offer better long-term conservation of pancreatic function at the expense of high perioperative major morbidity: a fair trade-off for benign or low-malignant potential pancreatic neoplasms-a single-centre experience. (Langenbecks Arch Surg. 2022).
• Patkar S, Gupta V, Khobragade K, Goel M. The reality of cholangiocarcinoma in India- real-world data from a tertiary referral centre. (HPB (Oxford). 2022).
• Chaudhari VA, Mitra A, Gupta V, Ostwal V, Ramaswamy A, Engineer R, Sirohi B, Shetty N, Bal M, DeSouza A, Bhandare MS, Shrikhande SV. Neoadjuvant therapy in borderline resectable pancreatic cancer: Outcomes in the era of changing practices and evolving evidence. (Surgery. 2022).
• Gupta V, Rao T, Raju K, Iyer RR, Ahmed SM, Shah M, Nagaraju R. Outcomes of Laparoscopic Optimal Interval Cytoreduction Surgery (LOICS) in Patients with Advanced Ovarian Cancers Having Low Burden Disease. (Indian J Surg Oncol. 2023).
• Bhandare MS, Gupta V, Chaudhari V, Nandy K, Ostwal V, Ramaswamy A, Nashikkar C, Engineer R, Krishnatry R, Shrikhande SV. Differential impact of incrementally elevated CA 19-9 levels on prognosis of resected pancreatic ductal adenocarcinoma. (HPB (Oxford). 2024).
• Chopde A, Gupta V, Jadhav A, Kumar R, Ramadwar M, Patkar S, Goel M. Neuroendocrine Tumours of Extrahepatic Biliary Tract: Report of Four Cases with Literature Review. (Indian J Surg Oncol. 2024).